John Arcaroli

John Arcaroli

Medicine, University of Colorado Denver Anschutz Medical Campus

Affiliated withUniversity of Colorado Denver Anschutz Medical Campus

Research Area

Biography

John Arcaroli has not added Biography.
If you are John Arcaroli and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Publication title

Cited by 23

2016

Other Publications

Article
Year
Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer.

Oncotarget| PubMed ID: 27385211

2016
2002
2002
2003
Evidence for extracellular superoxide dismutase as a mediator of hemorrhage-induced lung injury.

American journal of physiology. Lung cellular and molecular physiology| PubMed ID: 12618426

2003
Activation of gene expression in human neutrophils by high mobility group box 1 protein.

American journal of physiology. Cell physiology| PubMed ID: 12620891

2003
Early alterations in neutrophil activation are associated with outcome in acute lung injury.

American journal of respiratory and critical care medicine| PubMed ID: 12626346

2003
Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 12759445

2003
2004
Hemorrhage-induced acute lung injury is TLR-4 dependent.

American journal of physiology. Regulatory, integrative and comparative physiology| PubMed ID: 15072965

2004
Genetic polymorphisms and sepsis.

Shock (Augusta, Ga.)| PubMed ID: 16205313

2005
Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis.

American journal of respiratory and critical care medicine| PubMed ID: 16528020

2006
2007
2008
Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality.

American journal of respiratory and critical care medicine| PubMed ID: 18948423

2009
Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 20682712

2010
2010
2011
Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer models.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 22173548

2012
2012
Patient-derived tumour xenografts as models for oncology drug development.

Nature reviews. Clinical oncology| PubMed ID: 22508028

2012
2012
Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinib.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 22553375

2012
2013
2012
2012
2013
2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 23757356

2013
2013
2014
2015
2014
2014
2015
2015
2016
2015
2015
2016
2016
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.

Journal of the National Cancer Institute| PubMed ID: 27634934

2017